These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 13885183)

  • 1. [3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine.] (Segontin) in syndromes of coronary insufficiency. Preliminary note].
    DELLA PORTA P; LUCCHINI CR
    Minerva Cardioangiol; 1961 Sep; 9():533-6. PubMed ID: 13885183
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical observations on the use of a new synthetic agent (3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine, Segontin) in coronary insufficiency syndromes].
    CESARI L
    Gazz Int Med Chir; 1962 Sep; 66():1994-2004. PubMed ID: 14019763
    [No Abstract]   [Full Text] [Related]  

  • 3. [3,3-Diphenyl-N-(alpha-methylphenethyl)-propylamine].
    URBINATI G
    Clin Ter; 1961 Aug; 21():178-86. PubMed ID: 13779294
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experimentation with a new substance (3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine in syndromes caused by coronary insufficiency].
    DE FELICE D; ROSSETTO L
    Gazz Int Med Chir; 1962 Sep; 66():1976-84. PubMed ID: 14025758
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical evaluation of a preparation with antistenocardiac action, 3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine].
    PRETOLANI E
    Gazz Int Med Chir; 1963 May; 67():1011-21. PubMed ID: 13986080
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental and clinical observations on the action of a new anti-angina drug: 3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine lactate or FPDFPA].
    MIGHELI B; ANSELMINO A; BERT G; ANFOSSI F; BIANCO A; PUPITA F
    Clin Ter; 1963 Mar; 24():530-42. PubMed ID: 13935671
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical evaluation of the action of 3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine in coronary insufficiency].
    PARON R; DA BROI GL
    Gazz Int Med Chir; 1962 Nov; 66():2496-521. PubMed ID: 13941569
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preliminary observations on the therapy of angina pectoris with a new synthetic drug: 3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine].
    GUERRICCHIO G
    Minerva Cardioangiol; 1962 Nov; 10():766-71. PubMed ID: 13951123
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experiences with the clinical use of Segontin in coronary disease].
    OHIRA I; HAGIWARA M; UMEZONO T; TSUCHIYA T; IMAGAWA S; MATSUOKA K
    Chiryo; 1962 Aug; 44():1573-7. PubMed ID: 14481363
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of coronary circulatory disorders in internal practice with segontin].
    HAMANN E
    Landarzt; 1961 Nov; 37():1277-9. PubMed ID: 13904049
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical experiences with segontin].
    RATSCHOW M; SCHOOP W
    Med Klin; 1960 Aug; 55():1421-3. PubMed ID: 14436429
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experiences with segontin in internal medical practice].
    MENZEL M
    Ther Ggw; 1960 Sep; 99():432-4. PubMed ID: 13769511
    [No Abstract]   [Full Text] [Related]  

  • 13. [A double-blind experiment with the coronary therapeutic agent segontin].
    OVERKAMP H
    Med Klin; 1960 Aug; 55():1423-6. PubMed ID: 14429518
    [No Abstract]   [Full Text] [Related]  

  • 14. [INVESTIGATION ON THE BEHAVIOR OF 3,3-DIPHENYL-N-(ALPHA-METHYLPHENETHYL)-3-PROPYLAMINE (SEGONTIN) AGAINST THE ACTION OF NORADRENALINE].
    LINDNER E
    Arch Int Pharmacodyn Ther; 1963 Dec; 146():475-84. PubMed ID: 14103284
    [No Abstract]   [Full Text] [Related]  

  • 15. [RESEARCH ON THE ANTIFIBRILLATORY ACTION OF 3,3-DIPHENYL-N-(ALPHA-METHYLPHENETHYL)-3-PROPYLAMINE (SEGONTIN)].
    LINDNER E
    Arch Int Pharmacodyn Ther; 1963 Dec; 146():485-500. PubMed ID: 14103285
    [No Abstract]   [Full Text] [Related]  

  • 16. [Analogy of the effects of N-(1-methyl-2-phenylethyl)-1, 1-diphenyl-3-propylamine (Segontin) and reserpine on arterial pressure].
    SCHMITT H; SCHMITT H
    C R Seances Soc Biol Fil; 1962; 156():440-2. PubMed ID: 13908832
    [No Abstract]   [Full Text] [Related]  

  • 17. [PHENYL-PROPYL-DIPHENYL-PROPYL-AMINE (SEGONTIN) IN TREATMENT OF SYNDROMES DUE TO CORONARY INSUFFICIENCY IN PATIENTS OVER SEVENTY].
    FRANZINI C; TURRI C; MONTEROSSO A
    Minerva Cardioangiol; 1964 Dec; 12():515-27. PubMed ID: 14269033
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the therapy of coronary insufficiency].
    DUETSCH L
    Ther Ggw; 1960 May; 99():228-34. PubMed ID: 13818454
    [No Abstract]   [Full Text] [Related]  

  • 19. [A contribution to the therapy of coronary insufficiency].
    LEIMGARDT H
    Medizinische; 1959 Dec; No 49():2408-12. PubMed ID: 14415455
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of coronary insufficiency with Persantin].
    RIEGLER E
    Wien Z Inn Med; 1961 Mar; 42():140-2. PubMed ID: 13741533
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.